1965291-08-0
- Product Name：Ibrexafungerp citrate
- Molecular Formula：C50H75N5O11
- Purity：99%
- Molecular Weight：922.17
Product Details:
CasNo： 1965291-08-0
Molecular Formula： C50H75N5O11
Appearance： White to off-white solid
Delivery Time： 2 weeks after order
Throughput： 100KG/Month
Purity： 99%
Synonyms: MK 3118 citrate; (5S,6R,7R,10R,11R,14R,20R,21R)-21-[(2R)-2-Amino-2,3,3-trimethylbutoxy]-5,7,10,15-tetramethyl-7-[(2R)-3-methyl-2-butanyl]-20-[5-(4-pyridinyl)-1H-1,2,4-triazol-1-yl]-17-oxapentacyclo[13.3.3.01,14.02, 11.05,10]henicos-2-ene-6-carboxylic acid 2-hydroxy-1,2,3-propanetricarboxylate (1:1); 4H-1,4a-Propano-2H-phenanthro[1,2-c]pyran-7-carboxylic acid, 15-[(2R)-2-amino-2,3,3-trimethylbutoxy]-8-[(1R)-1,2-dimethylpropyl]-1,6,6a,7,8,9,10,10a,10b,11,12,12a-dodecahydro-1,6a,8,10a-tetramethyl-14-[5-(4-pyridinyl)-1H-1,2,4-triazol-1-yl]-, (6aS,7R,8R,10aR,10bR,12aR,14R,15R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (salt)
Uses:
Ibrexafungerp citrate (MK 3118 citrate) is an orally active β-1,3-glucan synthesis inhibitor, with potential antifungal activity. Ibrexafungerp citrate is an investigational agent for the treatment of Candida and Aspergillus infections.
Relevant Products
-
ApixabanCAS：503612-47-3
-
LefamulinCAS：1061337-51-6
-
IbrexafungerpCAS：1207753-03-4
